International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: onr:"swepub:oai:DiVA.org:oru-48994" > International renal...

1 of 1
Previous record
Next record
To hitlist

Details
MARC

McLaughlin, J. K.National Cancer Institute, Bethesda, Maryland, United States; International Epidemiology Institute, Rockville, Maryland, United States (author)

International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension

Article/chapterEnglish1995

Publisher, publication year, extent ...

New York, USA :John Wiley & Sons,1995
printrdacarrier

Numbers

LIBRIS-ID:oai:DiVA.org:oru-48994
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-48994URI
https://doi.org/10.1002/ijc.2910630212DOI

Supplementary language notes

Language:English
Summary in:English

Part of subdatabase

SwePubSwePub

Classification

Subject category:ref swepub-contenttype
Subject category:art swepub-publicationtype

Notes

Risk of renal-cell cancer in relation to use of diuretics, other anti-hypertensive medications and hypertension was assessed in a multi-center, population-based, case-control study conducted in Australia, Denmark, Germany, Sweden and the United States, using a shared protocol and questionnaire. A total of 1,732 histologically confirmed cases and 2,309 controls, frequency-matched to cases by age and sex, were interviewed. The association between renal-cell cancer and the drugs was estimated by relative risks (RRs) and 95% confidence intervals (CIs). Risks were increased among users of diuretics and other anti-hypertensive medications. After adjustment for hypertension, risk for diuretics was reduced to unity, except among long-term (15+ years) users. Risk for use of non-diuretic anti-hypertensive drugs remained significantly elevated and increased further with duration of use. Overall risk was not enhanced when both classes of medications were used. Excess risk was not restricted to any specific type of diuretic or anti-hypertensive drug and no trend was observed with estimated lifetime consumption of any particular type of product. The RR for hypertension after adjustment for diuretics and other anti-hypertensive medications was 1.4 (95% CI = 1.2-1.7), although among non-users of any anti-hypertensive medications, there was little excess risk associated with a history of hypertension. Exclusion of drug use that first occurred within 5 years of cancer diagnosis or interview did not alter the associations. Our findings suggest small effects on renal-cell cancer risk associated with hypertension and use of diuretics and other anti-hypertensive medications. However, because of potential misclassifications of these highly correlated variables, it is difficult to distinguish the effect of treatment from its indication, hypertension.

Subject headings and genre

MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
Antihypertensive Agents/*adverse effects
Carcinoma
Renal Cell/*etiology
Case-Control Studies
Diuretics/*adverse effects/classification
Humans
Hypertension/*complications
Kidney Neoplasms/*etiology
Odds Ratio
Risk

Added entries (persons, corporate bodies, meetings, titles ...)

Chow, W. H.National Cancer Institute, Bethesda, Maryland, United States (author)
Mandel, J. S.Division of Environmental Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States (author)
Mellemgaard, A.Danish Cancer Society, Copenhagen, Denmark (author)
McCredie, M.Cancer Epidemiology Research Unit, New South Wales Cancer Council, Kings Cross, Australia (author)
Lindblad, Per,1953-Department of Cancer Epidemiology, University Hospital, Uppsala, Sweden(Swepub:oru)pld (author)
Schlehofer, B.Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany (author)
Pommer, W.Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany (author)
Niwa, S.Westat Inc., Rockville, Maryland, United States (author)
Adami, H. O.Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany (author)
National Cancer Institute, Bethesda, Maryland, United States; International Epidemiology Institute, Rockville, Maryland, United StatesNational Cancer Institute, Bethesda, Maryland, United States (creator_code:org_t)

Related titles

In:International Journal of CancerNew York, USA : John Wiley & Sons63:2, s. 216-2210020-71361097-0215

Internet link

Find in a library

International Journal of Cancer (Search for host publication in LIBRIS)

To the university's database

1 of 1
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: McLaughlin, J. K ...; Chow, W. H.; Mandel, J. S.; Mellemgaard, A.; McCredie, M.; Lindblad, Per, 1 ...; show more...; Schlehofer, B.; Pommer, W.; Niwa, S.; Adami, H. O.; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cancer and Oncol ...

Articles in the publication: International Jo ...

By the university: Örebro University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se